Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers
Although we did not track any reported transactions in Q2, the first half of 2021 delivered three reported ENT practice acquisitions.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2024 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
Member of M&A Worldwide 